Fabio Stagno

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon et al. · JNCI Journal of the National Cancer Institute · 2011 · 424 citations · Full text

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia

Gianantonio Rosti, Francesca Palandri, Fausto Castagnetti et al. · Blood · 2009 · 210 citations · Full text

Age and d<scp>PCR</scp> can predict relapse in <scp>CML</scp> patients who discontinued imatinib: The <scp>ISAV</scp> study

Silvia Mori, Elisabetta Vagge, Philipp le Coutre et al. · American Journal of Hematology · 2015 · 207 citations · Full text

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub

Rocco Piazza, Vera Magistroni, Sara Redaelli et al. · Nature Communications · 2018 · 152 citations · Full text

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

Fabio Efficace, Michele Baccarani, Massimo Breccia et al. · Leukemia · 2013 · 135 citations

Hematological Malignancy, Quality Of Life, Important Factor +11